Unique Payer Network Strengthens InfuSystem (INFU)

Unique Payer Network Strengthens InfuSystem (INFU)

Fri, September 4, 2026 at 4:53 PM GMT+3 3 min read

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its "Small Cap Strategy". The letter can be downloaded here. The strategy returned 24.01% in the second quarter, outperforming the Russell 2000 Index's 21.49% return. Performance was positively affected by stock selection in health care and industrials, while the Fund's underweight position in information technology was the largest relative detractor as AI-related companies drove market gains. Small-cap equities benefited from strong earnings, resilient economic conditions, and easing geopolitical concerns, with technology leading sector performance while energy declined alongside lower oil prices. Despite the market's focus on AI, the Fund's strongest contributors came from businesses outside the theme, particularly in health care, defense-oriented companies, and tangible-asset industries. Looking ahead, the Fund remains focused on resilient, underfollowed companies tied to infrastructure, defense modernization, and essential industries where disciplined capital allocation and long-term demand can support value creation. Also, check the fund's top five holdings to see its best picks in 2026.

In its second-quarter 2026 investor letter, Diamond Hill Capital Small Cap Strategy highlighted InfuSystem Holdings, Inc. (NYSE:INFU). The strategy initiated a position in InfuSystem Holdings, Inc. (NYSE:INFU), a healthcare services provider that provides infusion pumps and related products and services, during the quarter. On September 03, 2026, InfuSystem Holdings, Inc. (NYSE:INFU) closed at $12.18 per share. Over the past month, InfuSystem Holdings, Inc. (NYSE:INFU) declined 2.48%, and its shares gained 19.88% over the past 52 weeks. InfuSystem Holdings, Inc. (NYSE:INFU) has a market capitalization of $241.79 million.

Diamond Hill Capital Small Cap Strategy stated the following regarding InfuSystem Holdings, Inc. (NYSE:INFU) in its Q2 2026 investor letter:

"InfuSystem Holdings, Inc. (NYSE:INFU) provides medical device management services, primarily supporting ambulatory infusion pumps used in cancer treatment, handling equipment logistics, maintenance and insurance reimbursement. We initiated a position as we believe the company benefits from a difficult-to-replicate payer network, improving profitability driven by operational efficiencies and a favorable product mix, and a strong balance sheet that supports disciplined capital allocation."

InfuSystem Holdings, Inc. (NYSE:INFU) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 12 hedge fund portfolios held InfuSystem Holdings, Inc. (NYSE:INFU) at the end of the second quarter which was 21 in the previous quarter. While we acknowledge the potential of InfuSystem Holdings, Inc. (NYSE:INFU) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

In another article, we covered InfuSystem Holdings, Inc. (NYSE:INFU) and shared a list of best small-cap stocks to buy according to Minerva Advisors. In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. This article is originally published at Insider Monkey.